Transcriptional regulation and spatial organisation of the human AML1/RUNX1 gene

Journal of Cellular Biochemistry

Volumn 112, Issue 8, 2011, Pages 1997-2005

  Markova, Elena N ^a   Kantidze, Omar L ^a   Razin, Sergey V ^a  

^a INSTITUTE OF GENE BIOLOGY   (Russian Federation)

Author keywords

Alternative promoters; Chromatin; Chromatin HUB; Chromosome conformation capture; Enhancers; Transcription control

Indexed keywords

TRANSCRIPTION FACTOR RUNX1;

ARTICLE; CHROMATIN; CONTROLLED STUDY; GENE CONTROL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; PRIORITY JOURNAL;

CHROMOSOMES, HUMAN, PAIR 21; CORE BINDING FACTOR ALPHA 2 SUBUNIT; HEK293 CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; INTRONS; JURKAT CELLS; K562 CELLS; RESPONSE ELEMENTS; TRANSCRIPTION, GENETIC;

VERTEBRATA;

EID: 79960343959     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23117     Document Type: Article

References (50)

1. Bakshi R, Hassan MQ, Pratap J, Lian JB, Montecino MA, van Wijnen AJ, Stein JL, Imbalzano AN, Stein GS,. 2010. The human SWI/SNF complex associates with RUNX1 to control transcription of hematopoietic target genes. J Cell Physiol 225: 569-576.
2. Bangsow C, Rubins N, Glusman G, Bernstein Y, Negreanu V, Goldenberg D, Lotem J, Ben-Asher E, Lancet D, Levanon D, Groner Y,. 2001. The RUNX3 gene-sequence, structure and regulated expression. Gene 279: 221-232. (Pubitemid 33132184)
3. Bartfeld D, Shimon L, Couture GC, Rabinovich D, Frolow F, Levanon D, Groner Y, Shakked Z,. 2002. DNA recognition by the RUNX1 transcription factor is mediated by an allosteric transition in the RUNT domain and by DNA bending. Structure 10: 1395-1407. (Pubitemid 35232385)
4. Bee T, Liddiard K, Swiers G, Bickley SR, Vink CS, Jarratt A, Hughes JR, Medvinsky A, de Bruijn MF,. 2009. Alternative Runx1 promoter usage in mouse developmental hematopoiesis. Blood Cells Mol Dis 43: 35-42.
5. Bee T, Swiers G, Muroi S, Pozner A, Nottingham W, Santos AC, Li PS, Taniuchi I, de Bruijn MF,. 2010. Nonredundant roles for Runx1 alternative promoters reflect their activity at discrete stages of developmental hematopoiesis. Blood 115: 3042-3050.
6. Bernardin F, Friedman AD,. 2002. AML1 stimulates G1 to S progression via its transactivation domain. Oncogene 21: 3247-3252. (Pubitemid 34548096)
7. Boyes J, Felsenfeld G,. 1996. Tissue-specific factors additively increase the probability of the all-or-none formation of a hypersensitive site. EMBO J 15: 2496-2507. (Pubitemid 26151189)
8. Busse CE, Krotkova A, Eichmann K,. 2005. The TCRbeta enhancer is dispensable for the expression of rearranged TCRbeta genes in thymic DN2/DN3 populations but not at later stages. J Immunol 175: 3067-3074. (Pubitemid 41170526)
9. Bystritskiy AA, Razin SV,. 2004. Breakpoint clusters: Reason or consequence? Crit Rev Eukaryot Gene Expr 14: 65-77. (Pubitemid 38581529)
10. de Laat W, Grosveld F,. 2003. Spatial organization of gene expression: The active chromatin hub. Chromosome Res 11: 447-459. (Pubitemid 37041205)
11. Dekker J, Rippe K, Dekker M, Kleckner N,. 2002. Capturing chromosome conformation. Science 295: 1306-1311. (Pubitemid 34157624)
12. Dowdy CR, Xie R, Frederick D, Hussain S, Zaidi SK, Vradii D, Javed A, Li X, Jones SN, Lian JB, van Wijnen AJ, Stein JL, Stein GS,. 2010. Definitive hematopoiesis requires Runx1 C-terminal-mediated subnuclear targeting and transactivation. Hum Mol Genet 19: 1048-1057.
13. Eggers JH, Stock M, Fliegauf M, Vonderstrass B, Otto F,. 2002. Genomic characterization of the RUNX2 gene of Fugu rubripes. Gene 291: 159-167. (Pubitemid 34722386)
14. Elagib KE, Goldfarb AN,. 2007. Oncogenic pathways of AML1-ETO in acute myeloid leukemia: Multifaceted manipulation of marrow maturation. Cancer Lett 251: 179-186. (Pubitemid 46669791)
15. Enver T, Zhang JW, Anagnou NP, Stamatoyannopoulos G, Papayannopoulou T,. 1988. Developmental programs of human erythroleukemia cells: Globin gene expression and methylation. Mol Cell Biol 8: 4917-4926.
16. Felsenfeld G, Boyes J, Chung J, Clark D, Studitsky V,. 1996. Chromatin structure and gene expression. Proceedings of the National Academy of Sciences of the United States of America 93: 9384-9388. (Pubitemid 26296616)
17. Flint J, Tufarelli C, Peden J, Clark K, Daniels RJ, Hardison R, Miller W, Philipsen S, Tan-Un KC, McMorrow T, Frampton J, Alter BP, Frischauf AM, Higgs DR,. 2001. Comparative genome analysis delimits a chromosomal domain and identifies key regulatory elements in the alpha globin cluster. Hum Mol Genet 10: 371-382. (Pubitemid 32166548)
18. Gavrilov AA, Razin SV,. 2008. Spatial configuration of the chicken alpha-globin gene domain: Immature and active chromatin hubs. Nucleic Acids Res 36: 4629-4640.
19. Ghozi MC, Bernstein Y, Negreanu V, Levanon D, Groner Y,. 1996. Expression of the human acute myeloid leukemia gene AML1 is regulated by two promoter regions. Proceedings of the National Academy of Sciences of the United States of America 93:1935-1940. (Pubitemid 26079858)
20. Hagege H, Klous P, Braem C, Splinter E, Dekker J, Cathala G, de Laat W, Forne T,. 2007. Quantitative analysis of chromosome conformation capture assays (3C-qPCR). Nat Protoc 2: 1722-1733.
21. Hromas R, Shopnick R, Jumean HG, Bowers C, Varella-Garcia M, Richkind K,. 2000. A novel syndrome of radiation-associated acute myeloid leukemia involving AML1 gene translocations. Blood 95: 4011-4013. (Pubitemid 30412883)
22. Hughes JR, Cheng JF, Ventress N, Prabhakar S, Clark K, Anguita E, De Gobbi M, de Jong P, Rubin E, Higgs DR,. 2005. Annotation of cis-regulatory elements by identification, subclassification, and functional assessment of multispecies conserved sequences. Proceedings of the National Academy of Sciences of the United States of America 102: 9830-9835. (Pubitemid 40993653)
23. Ito Y,. 2008. RUNX genes in development and cancer: Regulation of viral gene expression and the discovery of RUNX family genes. Adv Cancer Res 99: 33-76. (Pubitemid 350148068)
24. Kim JH, Lee S, Rho JK, Choe SY,. 1999. AML1, the target of chromosomal rearrangements in human leukemia, regulates the expression of human complement receptor type 1 (CR1) gene. Int J Biochem Cell Biol 31: 933-940. (Pubitemid 29406119)
25. Krimpenfort P, de Jong R, Uematsu Y, Dembic Z, Ryser S, von Boehmer H, Steinmetz M, Berns A,. 1988. Transcription of T cell receptor beta-chain genes is controlled by a downstream regulatory element. EMBO J 7: 745-750.
26. Levanon D, Groner Y,. 2004. Structure and regulated expression of mammalian RUNX genes. Oncogene 23: 4211-4219. (Pubitemid 38758586)
27. Levanon D, Negreanu V, Bernstein Y, Bar-Am I, Avivi L, Groner Y,. 1994. AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 23: 425-432. (Pubitemid 24308264)
28. Levanon D, Bernstein Y, Negreanu V, Ghozi MC, Bar-Am I, Aloya R, Goldenberg D, Lotem J, Groner Y,. 1996. A large variety of alternatively spliced and differentially expressed mRNAs are encoded by the human acute myeloid leukemia gene AML1. DNA Cell Biol 15: 175-185. (Pubitemid 26109134)
29. Levanon D, Goldstein RE, Bernstein Y, Tang H, Goldenberg D, Stifani S, Paroush Z, Groner Y,. 1998. Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors. Proceedings of the National Academy of Sciences of the United States of America 95: 11590-11595. (Pubitemid 28460459)
30. Levanon D, Glusman G, Bangsow T, Ben-Asher E, Male DA, Avidan N, Bangsow C, Hattori M, Taylor TD, Taudien S, Blechschmidt K, Shimizu N, Rosenthal A, Sakaki Y, Lancet D, Groner Y,. 2001. Architecture and anatomy of the genomic locus encoding the human leukemia-associated transcription factor RUNX1/AML1. Gene 262: 23-33. (Pubitemid 32155331)
31. Lichtinger M, Hoogenkamp M, Krysinska H, Ingram R, Bonifer C,. 2010. Chromatin regulation by RUNX1. Blood Cells Mol Dis 44: 287-290.
32. Maniatis T, Fritsch EF, Sambrook J,. 1989. Molecular cloning: A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press.
33. Nottingham WT, Jarratt A, Burgess M, Speck CL, Cheng JF, Prabhakar S, Rubin EM, Li PS, Sloane-Stanley J, Kong ASJ, de Bruijn MF,. 2007. Runx1-mediated hematopoietic stem-cell emergence is controlled by a Gata/Ets/SCL-regulated enhancer. Blood 110: 4188-4197. (Pubitemid 351377782)
34. Nucifora G, Rowley JD,. 1995. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood 86: 1-14.
35. Osato M, Asou N, Abdalla E, Hoshino K, Yamasaki H, Okubo T, Suzushima H, Takatsuki K, Kanno T, Shigesada K, Ito Y,. 1999. Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias. Blood 93: 1817-1824. (Pubitemid 29128481)
36. Otto F, Lubbert M, Stock M,. 2003. Upstream and downstream targets of RUNX proteins. J Cell Biochem 89: 9-18. (Pubitemid 36459094)
37. Palstra RJ, Tolhuis B, Splinter E, Nijmeijer R, Grosveld F, de Laat W,. 2003. The beta-globin nuclear compartment in development and erythroid differentiation. Nat Genet 35: 190-194. (Pubitemid 37187640)
38. Palstra RJ, Simonis M, Klous P, Brasset E, Eijkelkamp B, de Laat W,. 2008. Maintenance of long-range DNA interactions after inhibition of ongoing RNA polymerase II transcription. PLoS One 3: e1661.
39. Paulsson K, Bekassy AN, Olofsson T, Mitelman F, Johansson B, Panagopoulos I,. 2006. A novel and cytogenetically cryptic t(7;21)(p22;q22) in acute myeloid leukemia results in fusion of RUNX1 with the ubiquitin-specific protease gene USP42. Leukemia 20: 224-229. (Pubitemid 43148659)
40. Roumier C, Fenaux P, Lafage M, Imbert M, Eclache V, Preudhomme C,. 2003. New mechanisms of AML1 gene alteration in hematological malignancies. Leukemia 17: 9-16. (Pubitemid 36175882)
41. Speck NA, Gilliland DG,. 2002. Core-binding factors in haematopoiesis and leukaemia. Nat Rev Cancer 2: 502-513. (Pubitemid 37328932)
42. Splinter E, Grosveld F, de Laat W,. 2004. 3C technology: Analyzing the spatial organization of genomic loci in vivo. Methods Enzymol 375: 493-507. (Pubitemid 38124886)
43. Splinter E, Heath H, Kooren J, Palstra RJ, Klous P, Grosveld F, Galjart N, de Laat W,. 2006. CTCF mediates long-range chromatin looping and local histone modification in the beta-globin locus. Genes Dev 20: 2349-2354. (Pubitemid 44320383)
44. Sroczynska P, Lancrin C, Kouskoff V, Lacaud G,. 2009. The differential activities of Runx1 promoters define milestones during embryonic hematopoiesis. Blood 114: 5279-5289.
45. Tolhuis B, Palstra RJ, Splinter E, Grosveld F, de Laat W,. 2002. Looping and interaction between hypersensitive sites in the active beta-globin locus. Mol Cell 10: 1453-1465. (Pubitemid 36050885)
46. Vernimmen D, De Gobbi M, Sloane-Stanley JA, Wood WG, Higgs DR,. 2007. Long-range chromosomal interactions regulate the timing of the transition between poised and active gene expression. EMBO J 26: 2041-2051. (Pubitemid 46625789)
47. Westendorf JJ, Hiebert SW,. 1999. Mammalian runt-domain proteins and their roles in hematopoiesis, osteogenesis, and leukemia. J Cell Biochem Suppl 32-33: 51-58. (Pubitemid 30041810)
48. Zhang Y, Strissel P, Strick R, Chen J, Nucifora G, Le Beau MM, Larson RA, Rowley JD,. 2002. Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia. Proceedings of the National Academy of Sciences of the United States of America 99: 3070-3075. (Pubitemid 34240587)
49. Zhang L, Fried FB, Guo H, Friedman AD,. 2008. Cyclin-dependent kinase phosphorylation of RUNX1/AML1 on 3 sites increases transactivation potency and stimulates cell proliferation. Blood 111: 1193-1200. (Pubitemid 351213400)
50. Zhao X, Jankovic V, Gural A, Huang G, Pardanani A, Menendez S, Zhang J, Dunne R, Xiao A, Erdjument-Bromage H, Allis CD, Tempst P, Nimer SD,. 2008. Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity. Genes Dev 22: 640-653. (Pubitemid 351342436)